Luminex Corp (LMNX)-Financial and Strategic SWOT Analysis Review
April 2017
55
About the Report
About the Report
Luminex Corp (LMNX)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Business description-A detailed description of the company's operations and business divisions.
Corporate strategy-Analyst's summarization of the company's business strategy.
SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history-Progression of key events associated with the company.
Major products and services-A list of major products, services and brands of the company.
Key competitors-A list of key competitors to the company.
Key employees-A list of the key executives of the company.
Executive biographies-A brief summary of the executives' employment history.
Key operational heads-A list of personnel heading key departments/functions.
Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities-A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Luminex Corp (Luminex) is a medical devices company that carries out the development, manufacturing and marketing of proprietary biological testing technologies. The company offers wide range of products that include instruments, assays, reagents and accessories, software and replacement parts. Its proprietary technologies consist of xMAP technology, xTAG and MultiCode technology. Luminex offers its products to various markets such as clinical diagnostics; pharmaceutical drug discovery; biomedical research including personalized medicine, genomic and proteomic research, biodefense research and food safety. It also provides support and training services for its products. The company has operations in North America, Europe and Asia-Pacific th. Luminex is headquartered in Texas, the US.
Luminex Corp Key Recent Developments
Feb 06,2017: Luminex Reports Fourth Quarter And Full Year 2016 Results
Jan 09,2017: Luminex Announces Preliminary Revenue for Fourth Quarter 2016 and Issues 2017 Revenue Guidance
Dec 05,2016: Luminex wins R&D 100 Award for ARIES Systems
Oct 31,2016: Luminex Reports Third Quarter 2016 Results; Raises Full Year Guidance
Jul 28,2016: Luminex Reports Second Quarter 2016 Results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Products
Companies
Siemens Medical Solutions USA Inc Sequenom Inc Qiagen NV Life Technologies Corp Illumina, Inc. Hologic Inc Cepheid BioFire Diagnostics LLC Becton Dickinson and Co Affymetrix, Inc. Abbott Laboratories
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1-About the Company 6
Luminex Corp-Key Facts 6
Luminex Corp-Key Employees 7
Luminex Corp-Key Employee Biographies 8
Luminex Corp-Major Products and Services 9
Luminex Corp-Medical Equipment Pipeline Products Data 11
Luminex Corp Pipeline Products by Equipment Type 11
Luminex Corp Pipeline Products by Development Stage 12
Luminex Corp-History 15
Luminex Corp-Company Statement 19
Luminex Corp-Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Section 2-Company Analysis 24
Luminex Corp-Business Description 24
Luminex Corp-Corporate Strategy 25
Luminex Corp-SWOT Analysis 26
SWOT Analysis-Overview 26
Luminex Corp-Strengths 26
Luminex Corp-Weaknesses 27
Luminex Corp-Opportunities 28
Luminex Corp-Threats 29
Luminex Corp-Key Competitors 30
Section 3-Company Financial Ratios 31
Financial Ratios-Capital Market Ratios 31
Financial Ratios-Annual Ratios 32
Performance Chart 35
Financial Performance 35
Financial Ratios-Interim Ratios 36
Financial Ratios-Ratio Charts 37
Section 4-Company's Lifesciences Financial Deals and Alliances 38
Luminex Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 38
Luminex Corp, Medical Equipment, Deals By Type, 2011 to YTD 2017 39
Luminex Corp, Recent Deals Summary 40
Section 5-Company's Recent Developments 41
Feb 06, 2017: Luminex Reports Fourth Quarter And Full Year 2016 Results 41
Jan 09, 2017: Luminex Announces Preliminary Revenue for Fourth Quarter 2016 and Issues 2017 Revenue Guidance 42
Dec 05, 2016: Luminex wins R&D 100 Award for ARIES Systems 43
Oct 31, 2016: Luminex Reports Third Quarter 2016 Results; Raises Full Year Guidance 44
Jul 28, 2016: Luminex Reports Second Quarter 2016 Results 45
May 16, 2016: Nanosphere Announces First Quarter Results 46
May 02, 2016: Luminex Reports First Quarter 2016 Results 47
Apr 07, 2016: Luminex to Showcase CE-IVD Marked ARIES System, Revolutionary Software, and Assays at ECCMID Annual Meeting 48
Mar 21, 2016: Luminex Receives CE-IVD Mark for ARIES System 49
Mar 21, 2016: Luminex Receives CE-IVD Mark for ARIES HSV 1&2 Assay 50
Section 6-Appendix 51
Methodology 51
Ratio Definitions 51
About GlobalData 55
Contact Us 55
Disclaimer 55
List of Figure
List of Figures
Luminex Corp Pipeline Products by Equipment Type 11
Luminex Corp Pipeline Products by Development Stage 12
Luminex Corp, Performance Chart (2012-2016) 35
Luminex Corp, Ratio Charts 37
Luminex Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 38
Luminex Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017 39
List of Table
List of Tables
Luminex Corp, Key Facts 6
Luminex Corp, Key Employees 7
Luminex Corp, Key Employee Biographies 8
Luminex Corp, Major Products and Services 9
Luminex Corp Pipeline Products by Equipment Type 11
Luminex Corp Number of Pipeline Products by Development Stage 12
Luminex Corp Pipeline Products Summary by Development Stage 13
Luminex Corp, History 15
Luminex Corp, Other Locations 22
Luminex Corp, Subsidiaries 22
Luminex Corp, Key Competitors 30
Luminex Corp, Ratios based on current share price 31
Luminex Corp, Annual Ratios 32
Luminex Corp, Annual Ratios (Cont...1) 33
Luminex Corp, Annual Ratios (Cont...2) 34
Luminex Corp, Interim Ratios 36
Luminex Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 38
Luminex Corp, Medical Equipment, Deals By Type, 2011 to YTD 2017 39
Luminex Corp, Recent Deals Summary 40
Currency Codes 51
Capital Market Ratios 51
Equity Ratios 52
Profitability Ratios 52
Cost Ratios 53
Liquidity Ratios 53
Leverage Ratios 54
Efficiency Ratios 54
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.